GlassScriptPhysician profile
Evan Andrew Camarillo
NPI 1083398994
$762.57
in general payments reported to CMS, 2019-2025
19 companies · $763 in 2025
The $763 reported for 2025 was more than what 79% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $763.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $760 · Travel and Lodging: $2.75.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $759.82 |
| Travel and Lodging | $2.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $123.29 | 2025 | Kisunla |
| Abbvie INC. | $104.21 | 2025 | |
| Biogen, INC. | $70.58 | 2025 | Spinraza, Qalsody, Vumerity |
| Ucb, INC. | $64.54 | 2025 | Zilbrysq |
| Eisai INC. | $47.43 | 2025 | |
| Alnylam Pharmaceuticals INC. | $41.10 | 2025 | Amvuttra |
| Harmony Biosciences LLC | $38.27 | 2025 | |
| Otsuka America Pharmaceutical, INC. | $33.52 | 2025 | Rexulti |
| Neurelis, INC. | $32.68 | 2025 | Valtoco |
| Lundbeck LLC | $29.92 | 2025 | Vyepti |
| Impel Pharmaceuticals LLC | $23.61 | 2025 | Trudhesa |
| Genentech USA, INC. | $23.26 | 2025 | Ocrevus Zunovo |
| Tanabe Pharma America, INC. | $22.10 | 2025 | Radicava |
| Mallinckrodt Hospital Products INC. | $20.51 | 2025 | Acthar |
| Janssen Biotech, INC. | $20.37 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $18.55 | 2025 | Hizentra |
| Takeda Pharmaceuticals U.S.A., INC. | $16.67 | 2025 | Hyqvia |
| Acadia Pharmaceuticals INC | $16.01 | 2025 | Nuplazid |
| Axsome Therapeutics, INC. | $15.95 | 2025 | Sunosi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Evan Camarillo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.